No Title Attachment Date 7 [Press Release] Limbach Group adopts QuantaMatrix dRASTTM in routine clinical use 2021-12-15 6 [Press Release] QuantaMatrix to Debut on KOSDAQ on Wednesday (12/9) as IPO prices at $23.57 high end, raising $40.2mn 2020-12-09 5 [Press Release] QuantaMatrix, Applied for an Export License from the Korean Ministry of Food and Drug Safety for the COVID-19 Molecular Diagnostic Kit 2020-09-21 4 [Press Release] QuantaMatrix, Early Diagnosis Kit for Alzheimer's Disease Approved by the Ministry of Food and Drug Safety 2020-07-21 3 [Press Release] QuantaMatrix installs 12 dRAST Platforms - direct Rapid Antimicrobial Susceptibility Testing - in ten European Countries Download 2020-08-26 2 [Press Release] QuantaMatrix Passes Preliminary Review for KOSDAQ Listing 2020-06-26 1 [Press Release] QuantaMatrix Passes Technical Assessment, Accelerating Preparation for Listing in KOSDAQ 2019-12-18 1 Title Content
